相关实验视频
Updated: May 21, 2025
07:24
Home-Based Monitor for Gait and Activity Analysis
Published on: August 8, 2019
6.7K
评估脊柱肌肉缩的疾病进展,当前的差距和机会:叙述性综述
R Muni-Lofra1, G Coratti2, T Duong3
1The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 3BZ, UK.
Neuromuscular disorders : NMD
|March 22, 2025
概括
脊髓肌肉缩 (SMA) 是一种遗传性疾病,具有多种症状. 目前的评估捕捉疾病进展和治疗效应,但不断变化的患者结果需要进一步的评估方法.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 康复医学 康复医学 康复医学
背景情况:
- 脊髓肌肉缩 (SMA) 是一种遗传性神经肌肉疾病,其特征是肌肉逐渐衰弱和缩.
- 在SMA的表型呈现非常异质,从严重的运动发育停滞到较轻的障碍.
- 疾病严重程度评估传统上依赖于各种结果指标,按身体结构/功能,活动或参与进行分类.
研究的目的:
- 审查脊柱肌肉缩中使用的结果测量范围.
- 在新兴疾病修饰疗法的背景下,评估当前评估工具的充分性.
- 确定需要进一步开发SMA评估的领域.
主要方法:
- 对脊柱肌肉缩现有的结果措施的文献综述.
- 功能性和基于参与的结果措施的分析.
- 考虑新疗法对评估要求的影响.
主要成果:
- 有各种各样的结果测量方法,包括通用和特定疾病的功能评估.
- 参与度指标捕捉了患者报告的结果,如生活质量和日常活动.
- 现有的工具可以评估自然史和治疗效果,但可能需要增强.
结论:
- 目前的评估工具为评估SMA自然史和治疗疗效提供了重要的范围.
- 增加的生存率和患者症状的演变 (例如,疲劳,腹筋功能) 强调了需要精细和额外的评估措施.
- 进一步开发结果指标至关重要,以充分把握先进疗法在SMA管理中的影响.
更多相关视频
相关概念视频
01:15Parkinson's Disease: Overview
405
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
405
01:20Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K